期刊文献+

紫杉醇联合顺铂化疗配合放射治疗局部晚期鼻咽癌的疗效观察 被引量:2

Efficacy Observation of Radiotherapy Combined with Chemotherapy of Paclitaxel and Cisplatin for Local Advanced Nasopharyngeal Carcinoma
原文传递
导出
摘要 目的:观察紫杉醇联合顺铂化疗配合放射治疗局部晚期鼻咽癌的临床疗效。方法:将125例局部晚期鼻咽癌患者随机分为治疗组和对照组。治疗组63例先给予1周期的TP方案(紫杉醇135mg.m-2,静脉滴注3h,d1;顺铂20mg.m-2,静脉滴注,d1~5;每3周重复)诱导化疗,休息10d后开始放射治疗,并于放射治疗第1周末、第4周末和第7周末共给予3周期的TP方案同期化疗。对照组62例采用与治疗组相同的单纯放射治疗。治疗后观察2组疗效及不良反应发生情况。结果:治疗组病灶完全消退52例,部分消退6例,有效率为92.1%;对照组病灶完全消退39例,部分消退9例,有效率为77.4%,2组比较差异有统计学意义(P<0.05)。治疗组不良反应发生率高于对照组,且2组骨髓抑制和恶心呕吐的发生率比较差异有统计学意义(P<0.01)。结论:紫杉醇联合顺铂化疗有放射增敏作用,配合放射治疗局部晚期鼻咽癌能改善近期疗效,且毒副反应可以耐受,但长期疗效有待临床进一步观察。 To study clinical efficacy of radiotherapy combined with chemotherapy of paclitaxel and cisplatin for local advanced nasopharyngeal carcinoma (NPC) prospectively. METHODS: 125 patients with advanced local nasopharyngeal carci- noma were randomly divided into 2 groups: 63 patients in treatment group were given TP regimen (paclitaxel 135 mg. m-2 via i.v. gtt 3 h, d1; cisplatin 20 mg-m-2, d1-5; 3 weeks was a cycle) to induce chemotherapy. The radiotherapy was given after 10 days, and 3 cycles of chemotherapy with TP regimen were received at the is' weekend, 4th weekend and 7th weekend. 62 patients in con- trol groups were treated by radiotherapy alone. Radiation treatments were same in these 2 groups. RESULTS: There were 52 CR pa- tients and 6 PR patients in treatment group with effective rate of 92.1% ; there were 39 CR patients and 9 PR patients with effective rate of 77.4%. The effective rate of treatment group was significantly higher than that of control group, there was statistical signifi- cance (P〈0.05). The treatment group had more obvious side-effect of digestive tract and hematology(P〈0.01), which could be re- lieved after symptomatic treatment. But the patients could be tolerated, and succeed to finish treatment on schedule globally. CON- CLUSIONS: Paclitaxel and cisplatin have radiosensitization. The radiotherapy combined with TP chemotherapy for local advanced nasopharyngeal carcinoma is more effectively in the short term, and the side effects can be tolerated. But the long-term effect is re- mained to be observed.
出处 《中国药房》 CAS CSCD 北大核心 2011年第48期4549-4551,共3页 China Pharmacy
基金 广东省江门市科技计划项目(2009年)
关键词 局部晚期鼻咽癌 放射治疗 化疗 紫杉醇 顺铂 Local advanced nasopharyngeal carcinoma Radiotherapy Chemotherapy Paclitaxel Cisplatin
  • 相关文献

参考文献11

  • 1潘建基.鼻咽癌’92分期修订工作报告[J].中华放射肿瘤学杂志,2009,18(1):2-6. 被引量:261
  • 2孙燕,石远凯.内科肿瘤学[M].北京:人民卫生出版社,2007:785-788.
  • 3Chua DT, Sham JS, Kwong DL, et al. Treatment outcome after radiotherapy alone for patients with stage I - II nasopharyngeal carcinoma[J].Cancer, 2003,98 ( 1 ) : 74.
  • 4华贻军,洪明晃,罗东华,邱枋,郭灵,张国义.406例鼻咽癌患者预后多因素分析[J].中国肿瘤临床,2005,32(8):435-438. 被引量:60
  • 5Langendijk JA, Leemans CR, Buter J, et al. The additional value of chemotherapy to radiotherapy in locally advanced nasopharygeal carcinoma: a meta-analysis of the published literature[J]. J Clin Oncol, 2004,22 (22) : 4 604.
  • 6Lee AW, Lau WH, Tung SY, et al. Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group[J]. J Clin Oncol, 2005,23 (28) : 6 966.
  • 7Lin JC, Jan JS, Hou CY, et al. Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-flee survival[J]. J Clin Oncol, 2003,21(4) :631.
  • 8NCCN. Head and neck cancers (V.1.2006). NCCN clinical practice guidelines in oncology. NASO-1, NASO-2[R]. America: NCCN, 2006.
  • 9Ma BB, Chan AT. Recent perspectives in the role of chemotherapy in the manage- ment of advanced nasopharyngeal carcinoma[J]. Cancer, 2005,100(1 ) : 22.
  • 10吴煌坚,何宝贞,叶金辉,毛进星,梁海斯,黎凤娣.紫杉醇联合顺铂同期放疗综合治疗局部中晚期鼻咽癌[J].现代医院,2008,8(8):11-12. 被引量:3

二级参考文献44

共引文献356

同被引文献15

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部